Already using AlloSeq HCT and need to access technical documents? Login here.
Every minute of laboratory time is valuable. AlloSeq HCT can help you save time with a simple workflow and powerful analysis software, all while achieving high sensitivity chimerism monitoring.
Engraftment monitoring (chimerism) testing evaluates the success of a hematopoietic stem cell transplant by measuring the relative percentage of the recipient and the donor DNA in the recipient’s post-transplant specimen. Engraftment monitoring may assist in detecting disease relapse or graft failure.
AlloSeq HCT is a targeted NGS-based solution enabling precise measurement of engraftment following hematopoietic stem cell transplant for research applications.
Assay
HCT Software
The AlloSeq HCT assay enables the amplification and sequencing of 202 single nucleotide polymorphisms (SNPs) across all autosomal chromosomes. The AlloSeq HCT software automatically calculates % recipient and donor DNA in post-transplant samples.
HOT: Hands-on time (based on 48 samples). TAT: Turn around time.
AlloSeq HCT is available as CE/IVD in the EU and UK, and Research Use Only for the rest of the world. For local regulatory status, please contact CareDx. AlloSeq is a trademark or registered trademark of CareDx Inc. or its subsidiaries in the US or other countries. AlloSeq is a registered trademark with the US Patent and Trademark Office.
